Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

04 Sep, 2018, 08:00 BST Miracor Medical closes final tranche of Series-D, bringing the round to €30M

Funds will be used to support clinical and prepare commercial activities. Miracor Medical SA (Miracor Medical) today announced the final...


04 Sep, 2018, 07:00 BST Multicentre Randomised Controlled Trial Confirms the Significant Benefits of Phagenyx® Treatment for Tracheostomised Stroke Patients With Dysphagia

Phagenesis Ltd, a pioneering leader in the treatment of dysphagia, is pleased to announce today the publication of its most recent randomised...


04 Sep, 2018, 00:51 BST Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet

MicroPort Scientific Corporation ("MicroPort®", HK:0853) announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting...


31 Aug, 2018, 05:17 BST XingImaging announces Alzheimer's Disease PET imaging in Mainland China

XingImaging LLC, a radiopharmaceutical production and positron emission tomography (PET) acquisition company operating in Mainland China announced...


30 Aug, 2018, 08:30 BST BlueWind Medical Announces Positive Long-Term Results of the BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

Results from 36-month OPTIMIST Follow-Up study show BlueWind Renova™ is a safe, minimally invasive system that offers durable and significant...


30 Aug, 2018, 08:30 BST BlueWind Medical Announces Positive Long-Term Results of the BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

Results from 36-month OPTIMIST Follow-Up study show BlueWind Renova™ is a safe, minimally invasive system that offers durable and significant...


29 Aug, 2018, 09:30 BST CartiHeal Performs First Belgium Case in the Agili-C™ Implant IDE Multinational Pivotal Study

CartiHeal, developer of Agili-C, proprietary implant for the treatment of joint surface lesions, and the Principle Investigator Professor Peter...


28 Aug, 2018, 15:37 BST Real-world Evidence From GARFIELD-AF Shows Superior Reduction in Mortality With Non-vitamin K Antagonists Oral Anticoagulants (NOACs) vs. Vitamin K Antagonists (VKAs) in Newly Diagnosed Atrial Fibrillation

- High-risk patients on anticoagulants (AC) for stroke prevention also have 17% fewer deaths over 2 years of follow-up than patients...


28 Aug, 2018, 12:02 BST LimaCorporate Awarded With Two New ODEP Ratings for Physica ZUK

LimaCorporate is proud to announce that another milestone has been reached following the SMR Reverse ODEP Ratings in March 2018. Physica ZUK has...


28 Aug, 2018, 11:00 BST Electronic Cigarette Use May Reverse the Harm Resulting From Tobacco Smoking in COPD Patients, Even in the Long Term

A new study that was recently published in the International Journal of Chronic Obstructive Pulmonary Disease, led by Riccardo Polosa, MD, PhD...


28 Aug, 2018, 08:00 BST Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA®▼ (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice

- The Global ETNA-AF programme is a large and comprehensive single non-vitamin K oral anticoagulant (NOAC) repository of real-world data,...


28 Aug, 2018, 02:00 BST Wellthy Therapeutics Presents Real-world Evidence to Show Digital Therapeutics can Both Improve Patient Outcomes and aid HCPs in Decision Making

Results shared at the American Diabetes Association's (ADA) 78th Scientific Sessions Wellthy Therapeutics , a leading digital health company in...


27 Aug, 2018, 17:00 BST Corvia Medical Announces Strong Positive One-Year Data From REDUCE LAP-HF I Randomized, Sham-Controlled Clinical Trial

Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced one-year...


26 Aug, 2018, 13:00 BST Ozempic® Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline

Ozempic® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal...


23 Aug, 2018, 15:17 BST LGC Capital's Australian Medical Cannabis LP Little Green Pharma Becomes Market Leader by Becoming First Australian Company Authorized to Sell Locally-grown and Manufactured Medicinal Cannabis

/NOT FOR DISTRIBUTION IN THE UNITED STATES/ - Little Green Pharma becomes first Australian company authorized to sell locally-grown and...


23 Aug, 2018, 09:00 BST First U.S. Patients Receive Agili-C™ Implants

CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, and two LSU Health New Orleans orthopaedic...


22 Aug, 2018, 18:00 BST iHuman Team at ShanghaiTech University Deciphers the First Human Frizzled Receptor Structure

The Xu Laboratory at the iHuman Institute of ShanghaiTech University has deciphered the high-resolution crystal structure of the first human...


22 Aug, 2018, 14:27 BST COMPASS Pathways Receives FDA Approval for Psilocybin Therapy Clinical Trial for Treatment-resistant Depression

COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received...


22 Aug, 2018, 13:00 BST MagVenture, Inc: FDA Clears 3-Minute, Non-Pharmaceutical Depression Treatment

For people suffering from severe depression, the road to remission just became a lot shorter: The treatment is known as Transcranial Magnetic...


22 Aug, 2018, 07:00 BST Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy

- BC 007 shows excellent safety profile - Phase 2 initiation anticipated in Q42018 Drug developer Berlin Cures today announced the...


22 Aug, 2018, 06:58 BST Nordic Nanovector ASA: Results for the Second Quarter and First Half 2018

Nordic Nanovector ASA (OSE: NANO) announces its second quarter and first half 2018 results today. A presentation by the company's senior management...


21 Aug, 2018, 08:36 BST Frost & Sullivan Publishes Q2-2018 Update On Cellect Biotechnology Ltd.

Equity Research is published in the framework of the Tel Aviv Stock Exchange (TASE) Analysis Program Cellect Biotechnology Ltd. is developing...


21 Aug, 2018, 07:43 BST iCAN Signs MoU With Yom Chai for Crohn's Disease and Autism

The Directors of Ananda Developments Plc are pleased to announce that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis...


21 Aug, 2018, 06:30 BST BerGenBio ASA: Results for the Second Quarter and First Half 2018

- Encouraging clinical data emerging from several phase II trials with highly selective AXL inhibitor bemcentinib (BGB324) - Advanced lung cancer...


20 Aug, 2018, 15:00 BST Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018

- Satellite symposium will highlight the breadth of evidence collected since the establishment of the registry in 2009 - An...


Most Viewed Clinical Trials & Medical Discoveries